Inspira Technologies OXY B.H.N. Ltd. has announced securing a significant $22.5 million purchase order for its ART100 system, marking a major commercial milestone for the company. The order was placed by a privately held company outside the U.S., known for its strategic global presence and established connections with government and healthcare institutions. This development is seen as an affirmation of Inspira's technology and a step towards broader market deployment. The company is in advanced negotiations with additional healthcare and governmental partners, with further announcements anticipated soon. Full payment for this order is expected in 2025, and preparations for implementation are already underway. This order signifies Inspira's shift into full-scale revenue generation, contributing to its global commercial expansion strategy.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。